These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2817798)

  • 1. Mechanism of the antineoplastic action of lysozyme: evidence for host mediated effects.
    Sava G; Ceschia V; Pacor S
    Anticancer Res; 1989; 9(4):1175-80. PubMed ID: 2817798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic effects of egg-white lysozyme in mice bearing solid metastasizing tumors.
    Sava G; Perissin L; Zorzet S; Callerio C
    Anticancer Res; 1986; 6(2):183-6. PubMed ID: 3707053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse.
    Sava G; Ceschia V; Pacor S; Zorzet S; Perissin L
    Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):683-9. PubMed ID: 2622298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma.
    Pacor S; Giacomello E; Bergamo A; Clerici K; Zacchigna M; Boccu E; Sava G
    Anticancer Res; 1996; 16(5A):2559-64. PubMed ID: 8917351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma.
    Sava G; Ceschia V; Pacor S; Zabucchi G
    Anticancer Res; 1991; 11(3):1109-13. PubMed ID: 1888145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
    Orsolić N; Basić I
    Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for host-mediated antitumor effects of lysozyme in mice bearing the MCa mammary carcinoma.
    Sava G; Ceschia V; Zabucchi G
    Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1737-43. PubMed ID: 3208816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas.
    Sava G; Pacor S; Dasić G; Bergamo A
    Anticancer Res; 1995; 15(5B):1883-8. PubMed ID: 8572573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of GALT and activation of mesenteric lymph node lymphocytes by a modified lysozyme in CBA mice with MCa mammary carcinoma.
    Sava G; Bergamo A; Capozzi I; Clerici K; Pacor S; Gagliardi R; Giacomello E; Zacchigna M; Di Luca G; Boccu E
    J Exp Ther Oncol; 1996 Nov; 1(6):342-9. PubMed ID: 9414423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimetastatic action of orally administered lysozyme in mice bearing Lewis lung carcinoma.
    Sava G; Perissin L; Zorzet S
    Clin Exp Metastasis; 1988; 6(3):245-53. PubMed ID: 3349667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma.
    Sava G; Pacor S; Ceschia V; Zassinovich G; Mestroni G
    Anticancer Res; 1989; 9(3):787-90. PubMed ID: 2764524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride.
    Sava G; Pacor S; Nardon E; Dobrina A
    J Chemother; 1992 Aug; 4(4):228-34. PubMed ID: 1403079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranilast inhibits the growth and metastasis of mammary carcinoma.
    Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
    Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.
    Bergamo A; Gagliardi R; Scarcia V; Furlani A; Alessio E; Mestroni G; Sava G
    J Pharmacol Exp Ther; 1999 Apr; 289(1):559-64. PubMed ID: 10087050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice.
    Bregant F; Pacor S; Ghosh S; Chattopadhyay SK; Sava G
    Anticancer Res; 1993; 13(4):1011-7. PubMed ID: 8352519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A.
    Magnarin M; Bergamo A; Carotenuto ME; Zorzet S; Sava G
    Anticancer Res; 2000; 20(5A):2939-44. PubMed ID: 11062704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment.
    Pacor S; Zorzet S; Cocchietto M; Bacac M; Vadori M; Turrin C; Gava B; Castellarin A; Sava G
    J Pharmacol Exp Ther; 2004 Aug; 310(2):737-44. PubMed ID: 15075381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L; Hersh EM; Hunter N
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
    Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
    Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.